2021
DOI: 10.1007/s11033-021-06745-8
|View full text |Cite
|
Sign up to set email alerts
|

Identification of copy number variants in children and adolescents with autism spectrum disorder: a study from Turkey

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 44 publications
0
2
0
Order By: Relevance
“…The first was a 139 kb deletion in a case presented with craniorachischisis, cleft lip and palate, and bilateral adrenal hypoplasia (Chen et al 2013 ). The second was a de novo 209 kb duplication in a Turkish individual with ASD (Özaslan et al 2021 ). Regarding rare sequence-level variants, a heterozygous frameshift variant, NM_019619.4(PARD3): c.1012dupG (p.Glu338GlyfsTer26), was identified in six patients from a Chinese family manifesting nonsyndromic isolated cleft palate.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The first was a 139 kb deletion in a case presented with craniorachischisis, cleft lip and palate, and bilateral adrenal hypoplasia (Chen et al 2013 ). The second was a de novo 209 kb duplication in a Turkish individual with ASD (Özaslan et al 2021 ). Regarding rare sequence-level variants, a heterozygous frameshift variant, NM_019619.4(PARD3): c.1012dupG (p.Glu338GlyfsTer26), was identified in six patients from a Chinese family manifesting nonsyndromic isolated cleft palate.…”
Section: Discussionmentioning
confidence: 99%
“…S3). Pathogenic variants in CHD3 show variable expressivity in Snijders Blok–Campeau syndrome (OMIM 618205), while PARD3 was associated before with neural tube defects, cleft lip, cleft palate, ASD, and bilateral adrenal hypoplasia (Chen et al 2013 ; Cui et al 2022 ; Özaslan et al 2021 ; van der Spek et al 2022 ). The variant in CHD3 was a predicted splice-site variant, and we did not functionally validate its effect.…”
Section: Discussionmentioning
confidence: 99%